Review Finds Strongest Clinical Evidence for Purified CBD in Anxiety, Psychosis, PTSD, and Substance Abuse
A critical review of clinical trials using purified CBD (without THC) found the strongest evidence for anxiety (17 positive RCTs), psychosis/schizophrenia (8 RCTs), PTSD (4 RCTs), and substance abuse (3 RCTs), but not for pain or COVID.
Quick Facts
What This Study Found
The areas with the most clinical evidence for purified CBD were anxiety (7 uncontrolled + 17 RCTs), psychosis/schizophrenia (1 uncontrolled + 8 RCTs), PTSD (2 uncontrolled + 4 RCTs), and substance abuse (2 uncontrolled + 3 RCTs). Sleep had 7 positive uncontrolled studies but only 1 small RCT. Current RCT evidence did not support purified oral CBD for pain, COVID, cancer, Huntington's, or type 2 diabetes.
Key Numbers
Anxiety: 17 positive RCTs. Psychosis: 8 positive RCTs. PTSD: 4 positive RCTs. Substance abuse: 3 positive RCTs. Sleep: only 1 RCT. Pain: not supported.
How They Did This
Critical review of clinical studies using purified CBD products only (excluding products with THC or other phytochemicals). Organized by indication and evidence level.
Why This Research Matters
By focusing exclusively on purified CBD studies, this review strips away the confound of THC and other plant compounds, giving a clearer picture of what CBD alone can and cannot do.
The Bigger Picture
The review reveals a striking mismatch between consumer use patterns and evidence. CBD is most commonly marketed for pain and sleep, yet the strongest evidence supports anxiety and psychosis.
What This Study Doesn't Tell Us
Many trials tested only acute single-dose CBD. Several studied healthy volunteers. Many had small sample sizes. No meta-analysis conducted.
Questions This Raises
- ?Why is CBD widely used for pain when RCT evidence does not support this?
- ?Will large phase 3 trials confirm the anxiety and psychosis findings?
Trust & Context
- Key Stat:
- 17 positive RCTs for anxiety, 0 for pain: CBD evidence does not match market claims
- Evidence Grade:
- Comprehensive review limited to purified CBD studies, providing clean analysis but without meta-analytic methods.
- Study Age:
- Published 2023.
- Original Title:
- The therapeutic potential of purified cannabidiol.
- Published In:
- Journal of cannabis research, 5(1), 21 (2023)
- Authors:
- O'Sullivan, Saoirse Elizabeth(2), Jensen, Sanne Skov(2), Nikolajsen, Gitte Nykjaer, Bruun, Heidi Ziegler, Bhuller, Rhenu, Hoeng, Julia
- Database ID:
- RTHC-04821
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
What conditions does pure CBD actually work for?
The strongest evidence supports purified CBD for anxiety (17 RCTs), psychosis/schizophrenia (8 RCTs), PTSD (4 RCTs), and substance abuse (3 RCTs). Evidence for pain was not supportive.
Does CBD help with sleep?
Seven uncontrolled studies suggested sleep benefits, but only one small RCT has confirmed this, making the evidence weak.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-04821APA
O'Sullivan, Saoirse Elizabeth; Jensen, Sanne Skov; Nikolajsen, Gitte Nykjaer; Bruun, Heidi Ziegler; Bhuller, Rhenu; Hoeng, Julia. (2023). The therapeutic potential of purified cannabidiol.. Journal of cannabis research, 5(1), 21. https://doi.org/10.1186/s42238-023-00186-9
MLA
O'Sullivan, Saoirse Elizabeth, et al. "The therapeutic potential of purified cannabidiol.." Journal of cannabis research, 2023. https://doi.org/10.1186/s42238-023-00186-9
RethinkTHC
RethinkTHC Research Database. "The therapeutic potential of purified cannabidiol." RTHC-04821. Retrieved from https://rethinkthc.com/research/o-sullivan-2023-the-therapeutic-potential-of
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.